WANG; Youzhen

Patent Applications and Registrations

Patent applications and USPTO patent grants for WANG; Youzhen.The latest application filed is for "combination of a mcl-1 inhibitor and midostaurin, uses and pharmaceutical compositions thereof".

Company Profile

3.3.19

WANG; Youzhen - Newton MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination Of A Mcl-1 Inhibitor And Midostaurin, Uses And Pharmaceutical Compositions Thereof App 20220016118 - HALILOVIC; Ensar ; et al.	2022-01-20
Pharmaceutical Combinations App 20210386763 - GUERREIRO; Nelson ; et al.	2021-12-16
A Triple Pharmaceutical Combination Comprising Dabrafenib, Trametinib And An Erk Inhibitor App 20210121460 - Meyer; Matthew John ; et al.	2021-04-29
Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors Grant 10,507,201 - Buschmann , et al. Dec	2019-12-17
Combination Of A Bcl-2 Inhibitor And A Mcl-1 Inhibitor, Uses And Pharmaceutical Compositions Thereof App 20190240225 - WEI; Andrew ; et al.	2019-08-08
Use Of Ring-fused Bicyclic Pyridyl Derivatives As Fgfr4 Inhibitors App 20190231760 - BUSCHMANN; Nicole ; et al.	2019-08-01
Use Of Ring-fused Bicyclic Pyridyl Derivatives As Fgfr4 Inhibitors App 20180185341 - BUSCHMANN; Nicole ; et al.	2018-07-05
Pharmaceutical combination comprising co-administration of taxane and N-(1-cyclohexyl-2-{2-[4-(4-fluoro-benzoyl)-thiazol-2-yl]-pyrrolidin-1-yl}- -2-oxo-ethyl)-2-methylamino-propionamide or pharmaceutically acceptable salt(s) thereof Grant 8,906,936 - Jensen , et al. December 9, 2	2014-12-09
Anti-cxcr4 Antibodies And Methods Of Use App 20140314784 - Bedian; Vahe ; et al.	2014-10-23
Combination of Organic Compounds App 20130217719 - Jensen; Michael Rugaard ; et al.	2013-08-22
Combination Of An Iap Inhibitor And A Taxane For The Treatment Of A Proliferative Disease App 20130085153 - Jensen; Michael Rugaard ; et al.	2013-04-04
Compositions, Kits, And Methods For Identification, Assessment, Prevention, And Therapy Of Breast Cancer App 20110092388 - LILLIE; JAMES ; et al.	2011-04-21
Combinations of Organic Compounds App 20100324083 - JENSEN; Michael Rugaard ; et al.	2010-12-23
Compositions, Kits, And Methods For Identification, Assessment, Prevention, And Therapy Of Breast Cancer App 20100105051 - LILLIE; JAMES ; et al.	2010-04-29
Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer Grant 7,705,120 - Lillie , et al. April 27, 2	2010-04-27
Combinations of Organic Compounds App 20090005411 - Jensen; Michael Rugaard ; et al.	2009-01-01
Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer App 20080311573 - Lillie; James ; et al.	2008-12-18
Novel genes, compositions, kits, and methods for identification, assessment prevention, and therapy of breast cancer App 20030215805 - Lillie, James ; et al.	2003-11-20
Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer App 20030124128 - Lillie, James ; et al.	2003-07-03
Novel genes, compositions, kits and methods for identification, assessment, prevention, and therapy of breast cancer App 20030099974 - Lillie, James ; et al.	2003-05-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.